New blood thinner tested in heart patients – but trial stopped early
NCT ID NCT04723186
First seen May 31, 2026 · Last updated Jun 16, 2026 · Updated 1 time
Summary
This study tested a new drug called MT1002 in 6 adults who had a mild heart attack (NSTEMI) and needed a procedure to open blocked heart arteries (PCI). The goal was to see if the drug could safely control blood clotting during the procedure and reduce major bleeding afterward. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IU Health - BMH
Muncie, Indiana, 47303, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.